Stocks and Investing
Stocks and Investing
Fri, August 24, 2012
[ 07:41 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 06:20 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 03:42 AM ] - WOPRAI
[ 03:42 AM ] - WOPRAI
[ 03:42 AM ] - WOPRAI
[ 03:41 AM ] - WOPRAI
[ 03:41 AM ] - WOPRAI
[ 03:41 AM ] - WOPRAI
[ 03:40 AM ] - WOPRAI
[ 02:05 AM ] - Market Wire
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gena Wang Initiated (BMRN) at Buy and Held Target at $46 on, Aug 24th, 2012
Gena Wang of Barclays, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Buy and Held Target at $46 on, Aug 24th, 2012.
Gena has made no other calls on BMRN in the last 4 months.
There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Gena's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gena
- Matthew Harrison of "Morgan Stanley" Maintained at Strong Buy with Increased Target to $52 on, Monday, July 23rd, 2012